Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Philippe Duchateau , André Choulika , Laurent Poirot

ABSTRACT

The present invention relates to methods of developing genetically engineered, preferably non-alloreactive T-cells for immunotherapy. This method involves the use of RNA-guided endonucleases, in particular Cas9/CRISPR system, to specifically target a selection of key genes in T-cells. The engineered T-cells are also intended to express chimeric antigen receptors (CAR) to redirect their immune activity towards malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies using T-Cells for treating cancer and viral infections. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Philippe Duchateau", 
        "type": "Person"
      }, 
      {
        "name": "Andr\u00e9 Choulika", 
        "type": "Person"
      }, 
      {
        "name": "Laurent Poirot", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3390/v5112748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001463223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-01-405365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001745406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nmeth.2649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008703730", 
          "https://doi.org/10.1038/nmeth.2649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2013.04.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013935649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1232033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022072971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tibtech.2013.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031527623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jgg.2013.03.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031629107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ymthe.2005.07.688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038735299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt.2507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041881936", 
          "https://doi.org/10.1038/nbt.2507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-01-043737", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045180555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2013.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045630180", 
          "https://doi.org/10.1038/nrclinonc.2013.46"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The present invention relates to methods of developing genetically engineered, preferably non-alloreactive T-cells for immunotherapy. This method involves the use of RNA-guided endonucleases, in particular Cas9/CRISPR system, to specifically target a selection of key genes in T-cells. The engineered T-cells are also intended to express chimeric antigen receptors (CAR) to redirect their immune activity towards malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies using T-Cells for treating cancer and viral infections.

", "id": "sg:patent.US-9855297-B2", "keywords": [ "method", "T cell", "immunotherapy", "nuclease", "invention", "alloreactive T cell", "endonuclease", "target", "selection", "key gene", "T lymphocyte", "engineered T cell", "chimeric antigen receptor", "redirect", "immune activity", "infected cell", "adoptive immunotherapy", "Neoplasm", "viral infection" ], "name": "Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.433267.7", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-9855297-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:35", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_b670b59c.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-9855297-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-9855297-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-9855297-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-9855297-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

84 TRIPLES      14 PREDICATES      43 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-9855297-B2 schema:about anzsrc-for:3103
2 schema:author N4258d4af57a64ce7ab3f7053a2447395
3 schema:citation sg:pub.10.1038/nbt.2507
4 sg:pub.10.1038/nmeth.2649
5 sg:pub.10.1038/nrclinonc.2013.46
6 https://doi.org/10.1016/j.cell.2013.04.025
7 https://doi.org/10.1016/j.jgg.2013.03.013
8 https://doi.org/10.1016/j.tibtech.2013.04.004
9 https://doi.org/10.1016/j.ymthe.2005.07.688
10 https://doi.org/10.1126/science.1232033
11 https://doi.org/10.1182/blood-2010-01-043737
12 https://doi.org/10.1182/blood-2012-01-405365
13 https://doi.org/10.3390/v5112748
14 schema:description <p id="p-0001" num="0000">The present invention relates to methods of developing genetically engineered, preferably non-alloreactive T-cells for immunotherapy. This method involves the use of RNA-guided endonucleases, in particular Cas9/CRISPR system, to specifically target a selection of key genes in T-cells. The engineered T-cells are also intended to express chimeric antigen receptors (CAR) to redirect their immune activity towards malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies using T-Cells for treating cancer and viral infections.</p>
15 schema:keywords Neoplasm
16 T cell
17 T lymphocyte
18 adoptive immunotherapy
19 alloreactive T cell
20 chimeric antigen receptor
21 endonuclease
22 engineered T cell
23 immune activity
24 immunotherapy
25 infected cell
26 invention
27 key gene
28 method
29 nuclease
30 redirect
31 selection
32 target
33 viral infection
34 schema:name Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
35 schema:recipient https://www.grid.ac/institutes/grid.433267.7
36 schema:sameAs https://app.dimensions.ai/details/patent/US-9855297-B2
37 schema:sdDatePublished 2019-03-07T15:35
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N3a9e6b15ea804e239653b161828b4a84
40 sgo:license sg:explorer/license/
41 sgo:sdDataset patents
42 rdf:type sgo:Patent
43 N2b2c2d8de57b421397391208618c01e8 schema:name Philippe Duchateau
44 rdf:type schema:Person
45 N3a9e6b15ea804e239653b161828b4a84 schema:name Springer Nature - SN SciGraph project
46 rdf:type schema:Organization
47 N4258d4af57a64ce7ab3f7053a2447395 rdf:first N2b2c2d8de57b421397391208618c01e8
48 rdf:rest Nc6e552bacf4946f3aaccbacfb51f86b6
49 Na1ed6ed1dce74acf9c4e7f2ce8fbf623 schema:name Laurent Poirot
50 rdf:type schema:Person
51 Nc6e552bacf4946f3aaccbacfb51f86b6 rdf:first Nfc17cb83ac6441a6ad8ffff088d57738
52 rdf:rest Nf30528659b544ddbb056152818e5dc35
53 Nf30528659b544ddbb056152818e5dc35 rdf:first Na1ed6ed1dce74acf9c4e7f2ce8fbf623
54 rdf:rest rdf:nil
55 Nfc17cb83ac6441a6ad8ffff088d57738 schema:name André Choulika
56 rdf:type schema:Person
57 anzsrc-for:3103 schema:inDefinedTermSet anzsrc-for:
58 rdf:type schema:DefinedTerm
59 sg:pub.10.1038/nbt.2507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041881936
60 https://doi.org/10.1038/nbt.2507
61 rdf:type schema:CreativeWork
62 sg:pub.10.1038/nmeth.2649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008703730
63 https://doi.org/10.1038/nmeth.2649
64 rdf:type schema:CreativeWork
65 sg:pub.10.1038/nrclinonc.2013.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045630180
66 https://doi.org/10.1038/nrclinonc.2013.46
67 rdf:type schema:CreativeWork
68 https://doi.org/10.1016/j.cell.2013.04.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013935649
69 rdf:type schema:CreativeWork
70 https://doi.org/10.1016/j.jgg.2013.03.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031629107
71 rdf:type schema:CreativeWork
72 https://doi.org/10.1016/j.tibtech.2013.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031527623
73 rdf:type schema:CreativeWork
74 https://doi.org/10.1016/j.ymthe.2005.07.688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038735299
75 rdf:type schema:CreativeWork
76 https://doi.org/10.1126/science.1232033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022072971
77 rdf:type schema:CreativeWork
78 https://doi.org/10.1182/blood-2010-01-043737 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045180555
79 rdf:type schema:CreativeWork
80 https://doi.org/10.1182/blood-2012-01-405365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001745406
81 rdf:type schema:CreativeWork
82 https://doi.org/10.3390/v5112748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001463223
83 rdf:type schema:CreativeWork
84 https://www.grid.ac/institutes/grid.433267.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...